Certified by Founder Lodge
Spear Bio
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
• Spear Bio is meeting a growing market need for ultrasensitive immunoassays in smaller samples.
• Our platform, based on technology licensed from Harvard University, can detect single-digit
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 30 ,2023 | Seed | Undisclosed Amount | |
| July, 30 ,2024 | Series A | $45,000,000.00 |
Maverick Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
